-
1
-
2
The safety, tolerability, pharmacokinetics, and pharmacodynamics of nebulized pegylated interferon α-2b in healthy adults: a randomized phase 1 trial
Published 2025-05-01Subjects: “…Pegylated interferon α-2b…”
Get full text
Article -
3
-
4
Is Combined Bulevirtide and Pegylated Interferon Therapy for Chronic Hepatitis D Superior over Bulevirtide Monotherapy?
Published 2020-09-01Subjects: Get full text
Article -
5
Treatment of hepatitis C in liver transplant recipients in the Moscow Center for Liver Transplantation within 10 years
Published 2016-01-01Subjects: Get full text
Article -
6
Treatment for recurrent HCV infection after liver transplantation for final stages of chronic hepatitis С
Published 2018-08-01Subjects: Get full text
Article -
7
DIFFERENT COURSES OF HBV INFECTION AFTER LIVER TRANSPLANTATION
Published 2011-06-01Subjects: Get full text
Article -
8
Successful treatment of hairy cell leukaemia with pegylated interferon-alpha-2A
Published 2025-05-01Subjects: Get full text
Article -
9
-
10
İnterferon ve ribavirin tedavisiyle gelişen plevral efüzyon
Published 2015-09-01Subjects: Get full text
Article -
11
Evaluation of the long-term outcomes of patients with hepatitis delta
Published 2025-01-01Subjects: Get full text
Article -
12
-
13
-
14
-
15
Success of early antiviral monotherapy with pegylated interferon α-2a for posttransplantation fibrosing cholestatic hepatitis C (a clinical case)
Published 2018-08-01Subjects: Get full text
Article -
16
NEW APPROACHES TO THERAPY OF CLASSICAL PH-NEGATIVE MYELOPROLIFERATIVE DISEASES: THE EXPERIENCE OF EARLY THERAPY WITH CEPEGINTERFERON ALPHA-2B
Published 2018-05-01Subjects: Get full text
Article -
17
Early virologic response to сеpeginterferon alfa-2b in combination with ribavirin in treatment of patients with chronic hepatitis C
Published 2014-09-01Subjects: Get full text
Article -
18
Adding pegylated interferon-α to nucleos(t)ide analogs improves HBsAg clearance in chronic hepatitis B with low-level viremia
Published 2025-08-01Subjects: Get full text
Article -
19
Mechanisms underlying delayed loss of HBeAg and HBV DNA following HBsAg seroclearance in PEG-IFNα treated patients of chronic hepatitis B
Published 2025-12-01Subjects: Get full text
Article -
20